On March 14, 2022, the VYNE Therapeutics Inc. named Tyler Zeronda as the Chief Financial Officer and Treasurer of the Company effective immediately. Mr. Zeronda, 36, has been serving as the Company's Interim Chief Financial Officer and Treasurer since June 2021. Prior to his appointment as Interim Chief Financial Officer, Mr. Zeronda served as Vice President of Finance of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.73 USD | -1.44% | -3.53% | +17.17% |
May. 09 | Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q1 Revenue $98,000 | MT |
May. 09 | VYNE Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.17% | 38.49M | |
+34.35% | 705B | |
+31.20% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.92% | 238B | |
-3.56% | 210B | |
+10.04% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- VYNE Therapeutics Inc. Appoints Tyler Zeronda as the Chief Financial Officer